STRAWBEAR ENT released its interim results, with a gross profit of 62.942 million yuan and a relatively stable net asset value
STRAWBEAR ENT released its interim results for the period ending June 30, 2025, with revenue of 446 million yuan and a gross profit of 62.942 million yuan. The company occupies an important position in the content market through an innovative series strategy, with short series such as "Bleach" and "In the World" performing excellently. During the reporting period, the net asset value remained stable at 1.754 billion yuan and 1.753 billion yuan, respectively
According to the Zhitong Finance APP, STRAWBEAR ENT (02125) released its interim results for the six months ending June 30, 2025, with revenue of 446 million yuan (RMB, the same below) and a gross profit of 62.942 million yuan.
The announcement stated that in the first half of 2025, the company positioned itself in the content market's future track through an innovative series strategy of "small but beautiful boutique," occupying a strategically valuable hub position in the long-short drama competition with high quality, fast pace, strong resonance, and new themes of "short series." The episodic content that has been aired during the reporting period, such as "Bleach," "In the World," and "Above the Clouds," are all excellent works developed under the company's differentiated strategic development, with their discussion heat across all platforms, recognition in the domestic and international industry, and broadcasting performance ranking among the top.
As of June 30, 2025, and December 31, 2024, the net asset value remained relatively stable at approximately 1.754 billion yuan and approximately 1.753 billion yuan, respectively
